The Major Role of Type 2 Inflammation in Asthma: From the Perspective of Immunological Mechanism
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/5663596 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioMed Research International, online erschienen am 20.01.2026. Verfasst von Lanying Cheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guan…. Hauptthemen laut MEDLINE: Asthma, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Respiratory Disease.
Abstract (Originalsprache)
Asthma is a heterogeneous disease that affects individuals of diverse age groups globally and exhibits variable responses to different treatments. Type 2 inflammation contributes to the pathogenesis of asthma through the production of cytokines IL‐4, IL‐5, and IL‐13, thereby inducing characteristic features of asthma such as elevated eosinophil levels and airway hyperresponsiveness. The findings of the current study indicate that over 50% of individuals suffering from asthma exhibit Type 2 inflammation, with a higher prevalence observed in severe asthma. Moreover, biologics specifically designed to target Type 2 inflammation not only demonstrate favorable outcomes in treating severe asthma but also offer promising prospects for managing this condition. Therefore, it is of paramount importance to comprehend the intricate mechanisms of Type 2 inflammation in asthma. This article is aimed at providing an overview of the involvement of structural cells, innate immune cells, and adaptive immune cells in relation to Type 2 inflammation in asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Pulmonology, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou, China, gzhmc.edu.cn.
ORCID-Profile: Lanying Cheng, Lihong Sun
Förderung
- State Key Laboratory of Respiratory Disease
Zitieren
APA
Cheng, L., & Sun, L. (2026). The Major Role of Type 2 Inflammation in Asthma: From the Perspective of Immunological Mechanism. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/5663596
Vancouver
Cheng L, Sun L. The Major Role of Type 2 Inflammation in Asthma: From the Perspective of Immunological Mechanism. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/5663596
BibTeX
@article{Cheng2026,
author = {Cheng, Lanying and Sun, Lihong},
title = {The Major Role of Type 2 Inflammation in Asthma: From the Perspective of Immunological Mechanism},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/5663596}
}
EUVIMED